| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT06350110 | Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus… | Systemic Lupus Erythematosus | Recruiting |
| NCT06538012 | TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer | Lung Cancer | Recruiting |
| NCT06399107 | Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating… | Sickle Cell Disease | Recruiting |
| NCT06428188 | Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory… | Autoimmune Diseases | Recruiting |
| NCT06530303 | Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum… | Colorectal Cancer | Recruiting |
| NCT06640582 | TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and… | Brain Tumor | Recruiting |
| NCT06420063 | Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML | AML | Recruiting |
| NCT06420076 | Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia… | T Cell Lymphoma | Recruiting |
| NCT06532799 | TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and… | Stomach Cancer | Recruiting |
| NCT06532812 | TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast… | Breast Cancer | Recruiting |
| NCT07032129 | Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory… | Multiple Myeloma | Recruiting |
| NCT07066982 | Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With… | Sarcoma | Recruiting |
| NCT07066995 | Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer | Pancreatic Cancer | Recruiting |
| NCT07067255 | Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer | Ovarian Cancer | Recruiting |
| NCT06213636 | Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia… | Acute Lymphoblastic Leukemia, Adult B-Cell | Recruiting |
| NCT07410494 | Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced… | Cancer | Recruiting |
| NCT07410676 | EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors | Cancer | Recruiting |